Revvity, Inc. (NYSE: RVTY) announced on November 13, 2026, that it will host its 2026 Investor Day. The event is scheduled to begin at 9:00 a.m. EST and will feature Prahlad Singh, the company’s President and Chief Executive Officer, alongside members of the senior leadership team.
Under the theme "Powering Scientific Intelligence," the company intends to outline its strategic priorities, recent operational initiatives, and long-range financial outlook. Revvity stated that it will demonstrate how its portfolio connects biology, experimental data, and scientific insights to support AI-enabled discovery workflows through specialized research, diagnostics, and software capabilities.
The company highlighted three key areas for the event:
- A differentiated portfolio: Strong positions across attractive Life Sciences and Diagnostics markets, supported by innovative research solutions, specialized diagnostic technologies, and leading software capabilities.
- Positioned for the future of scientific discovery: Unique capabilities to connect biology, experimental data, and scientific insights to support AI-enabled discovery workflows and the demand for high-quality experimental evidence.
- Compelling long-term value creation: Continued execution of efforts to simplify the organization, optimize operational performance, and advance strategic priorities to support above-market growth and margin expansion.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company serves customers across pharmaceutical and biotech, diagnostic labs, academia, and governments, with 2025 revenue of $2.9 billion and approximately 11,000 employees.
